Callisto Pharmaceuticals’ Program To Develop Biowarfare Vaccines Featured In Audio Interview

LOS ANGELES--(BUSINESS WIRE)--Dec. 16, 2005--HomelandInsights.com, http://www.homelandinsights.com, the online source for exclusive investor information in the homeland security and defense market, announced today that it will debut an audio interview with Dr. Gary S. Jacob, CEO and Chief Scientific Officer of Callisto Pharmaceuticals Inc. (AMEX:KAL) (FWB:CA4), a developer of new drug treatments in the fight against cancer and other major health threats, including the threat of bioterrorism.

MORE ON THIS TOPIC